ARCHIVES

Turmoil in Texas: SEC Issues Subpoena to AVEO on Tivozanib

This article is from The Cancer Letter archive.

Vol. 39 No. 28 | July 12, 2013

Download PDF Visit The Full Archive

Related Articles

CCRU-CCSP Report At Closed Session “Declassified” Discusses Review

December 3, 1982

Clinical Research: Enough Studies Done, Time For Solutions, CSR Report Says

February 20, 1998

In Brief: Robert Cooper, Regional Cancer Center Director, Dead At 59; NCI Critic Epstein Invited to NCAB

April 3, 1992

“Bring Contracts Under Control, Save $100,00 A Year,” Samuels Tells NCI

November 2, 1979

Phase III Trial Demonstrates Early Docetaxel Combined With ADT Can Extend Survival

December 27, 2013

UICC Congress Urges World Commitment To Cancer Prevention.

July 14, 2006